IndraLab

Statements


USP46 inhibits XRCC1. 2 / 2
| 2

reach
"Our data indicate that USP46 represses RCC tumor progression via the inhibition of the AKT signaling pathway."

reach
"We described a new mechanism by which USP46 inhibits RCC survival via the downregulation of the AKT signaling pathway."